PF-06821497 Mechanism of Action: EZH2 Inhibition in Prostate Cancer Cell Research

PF-06821497 MOA:Targeting EZH2/Epigenetic Regulation for Prostate Cancer

🎯 check PF-06821497 product page

PF-06821497 is a highly selective EZH2 inhibitor. It blocks PRC2 signaling by reducing H3K27me3, inhibiting cancer cell growth.

Primary Applications and Mechanism of Action